These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 18176865)

  • 1. Autoantibody-mediated disorders of the central nervous system.
    Irani S; Lang B
    Autoimmunity; 2008 Feb; 41(1):55-65. PubMed ID: 18176865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New autoantibody mediated disorders of the central nervous system.
    Lang B; Dale RC; Vincent A
    Curr Opin Neurol; 2003 Jun; 16(3):351-7. PubMed ID: 12858073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.
    Saiz A; Blanco Y; Sabater L; González F; Bataller L; Casamitjana R; Ramió-Torrentà L; Graus F
    Brain; 2008 Oct; 131(Pt 10):2553-63. PubMed ID: 18687732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aquaporin-4 autoantibodies in a paraneoplastic context.
    Pittock SJ; Lennon VA
    Arch Neurol; 2008 May; 65(5):629-32. PubMed ID: 18474738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emerging relationship between neuromyelitis optica and systemic rheumatologic autoimmune disease.
    Wingerchuk DM; Weinshenker BG
    Mult Scler; 2012 Jan; 18(1):5-10. PubMed ID: 22146604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune channelopathies.
    Buckley C; Vincent A
    Nat Clin Pract Neurol; 2005 Nov; 1(1):22-33. PubMed ID: 16932489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responses to and Outcomes of Treatment of Autoimmune Cerebellar Ataxia in Adults.
    Jones AL; Flanagan EP; Pittock SJ; Mandrekar JN; Eggers SD; Ahlskog JE; McKeon A
    JAMA Neurol; 2015 Nov; 72(11):1304-12. PubMed ID: 26414229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-aquaporin-4 antibody induces astrocytic cytotoxicity in the absence of CNS antigen-specific T cells.
    Kinoshita M; Nakatsuji Y; Kimura T; Moriya M; Takata K; Okuno T; Kumanogoh A; Kajiyama K; Yoshikawa H; Sakoda S
    Biochem Biophys Res Commun; 2010 Mar; 394(1):205-10. PubMed ID: 20188706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Which role of antineural autoantibodies in central nervous system diseases?].
    Honnorat J
    Rev Neurol (Paris); 2008 May; 164(5):403-4. PubMed ID: 18555871
    [No Abstract]   [Full Text] [Related]  

  • 10. [Neuromyelitis optica: a separate disease entity associated with aquaporin-4-antibodies].
    Jordan B; Eger K; Kornhuber ME; Zierz S
    Fortschr Neurol Psychiatr; 2008 Jan; 76(1):21-7. PubMed ID: 18189220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune channelopathies and related neurological disorders.
    Vincent A; Lang B; Kleopa KA
    Neuron; 2006 Oct; 52(1):123-38. PubMed ID: 17015231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody to aquaporin-4 in the long-term course of neuromyelitis optica.
    Jarius S; Aboul-Enein F; Waters P; Kuenz B; Hauser A; Berger T; Lang W; Reindl M; Vincent A; Kristoferitsch W
    Brain; 2008 Nov; 131(Pt 11):3072-80. PubMed ID: 18945724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune channelopathies: well-established and emerging immunotherapy-responsive diseases of the peripheral and central nervous systems.
    Vincent A
    J Clin Immunol; 2010 May; 30 Suppl 1():S97-102. PubMed ID: 20387102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay.
    Hayakawa S; Mori M; Okuta A; Kamegawa A; Fujiyoshi Y; Yoshiyama Y; Mitsuoka K; Ishibashi K; Sasaki S; Hattori T; Kuwabara S
    J Neuroimmunol; 2008 May; 196(1-2):181-7. PubMed ID: 18462810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutamic acid decarboxylase autoantibodies and neurological disorders.
    Vianello M; Tavolato B; Giometto B
    Neurol Sci; 2002 Oct; 23(4):145-51. PubMed ID: 12536283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies in patients with gut motility disorders and enteric neuropathy.
    Törnblom H; Lang B; Clover L; Knowles CH; Vincent A; Lindberg G
    Scand J Gastroenterol; 2007 Nov; 42(11):1289-93. PubMed ID: 17918010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuronal central nervous system syndromes probably mediated by autoantibodies.
    Chefdeville A; Honnorat J; Hampe CS; Desestret V
    Eur J Neurosci; 2016 Jun; 43(12):1535-52. PubMed ID: 26918657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebellar ataxia after malaria.
    Teo JT; Swayne OB; Silber E
    Neurology; 2009 Jul; 73(1):73-4. PubMed ID: 19564588
    [No Abstract]   [Full Text] [Related]  

  • 19. Fundamental Mechanisms of Autoantibody-Induced Impairments on Ion Channels and Synapses in Immune-Mediated Cerebellar Ataxias.
    Mitoma H; Honnorat J; Yamaguchi K; Manto M
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32668612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical markers of autoimmune diseases of the nervous system.
    Tumani H; Brettschneider J
    Curr Pharm Des; 2012; 18(29):4556-63. PubMed ID: 22612740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.